Golden State Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Golden State Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248	Buy	+25	New	+$209	﹤0.01%	1563

Other funds holding DNA

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Golden State Wealth Management's DNA Position: Q2 2026 in Review

Golden State Wealth Management opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 25 shares worth $248. The stake represents ﹤0.01% of the portfolio and ranks #1563 among its holdings.

19 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Golden State Wealth Management held 25 shares of Ginkgo Bioworks worth $248 as of Q2 2026.
Ginkgo Bioworks was a new Golden State Wealth Management position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1563 holding.
19 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.